PPP2CA and breast carcinoma: Second, small-molecule stabilizers targeting the PPP2R1A-PP2Ac complex interface (e.g., DT-061) have demonstrated the potential to restore PP2A’s tumor-suppressing function in various cancer models, including lung and breast cancer (46).